Literature DB >> 29799933

On the Marketing and Use of Pharmacogenetic Tests for Psychiatric Treatment.

George S Zubenko1, Barbara R Sommer2, Bruce M Cohen3,4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29799933     DOI： 10.1001/jamapsychiatry.2018.0834

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN： 2168-622X            Impact factor:   21.596


× No keyword cloud information.
  11 in total

1.  Harnessing Progress in Psychiatric Genetics to Advance Population Mental Health.

Authors:  Kathleen Ries Merikangas; Alison K Merikangas
Journal:  Am J Public Health       Date:  2019-06       Impact factor: 9.308

2.  Editorial: Beyond Red Light, Green Light: Examining the Role of Pharmacogenomics in Evidence-Based Care in Child and Adolescent Psychiatry.

Authors:  Lisa B Namerow; Laura B Ramsey; Salma Malik; Samuele Cortese; Jeffrey R Strawn
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-11-10       Impact factor: 8.829

Review 3.  Signature-based approaches for informed drug repurposing: targeting CNS disorders.

Authors:  Rammohan Shukla; Nicholas D Henkel; Khaled Alganem; Abdul-Rizaq Hamoud; James Reigle; Rawan S Alnafisah; Hunter M Eby; Ali S Imami; Justin F Creeden; Scott A Miruzzi; Jaroslaw Meller; Robert E Mccullumsmith
Journal:  Neuropsychopharmacology       Date:  2020-06-30       Impact factor: 8.294

4.  Pharmacogenetic testing in psychiatric inpatients with polypharmacy is associated with decreased medication side effects but not via medication changes.

Authors:  Andrea R Collins; Simon Kung; Jacqueline T Ho; Jessica A Wright; Kristina C Dammen; Emily K Johnson; Maria I Lapid; Jonathan G Leung
Journal:  J Psychiatr Res       Date:  2020-05-10       Impact factor: 5.250

5.  Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study.

Authors:  Tamara Bar-Yosef; Wessal Hussein; Ofer Yitzhaki; Odeya Damri; Limor Givon; Carmit Marom; Vlada Gurman; Joseph Levine; Yuly Bersudsky; Galila Agam; Dorit Ben-Shachar
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

6.  Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications.

Authors:  Marin Veldic; Ahmed T Ahmed; Caren J Blacker; Jennifer R Geske; Joanna M Biernacka; Kristin L Borreggine; Katherine M Moore; Miguel L Prieto; Jennifer L Vande Voort; Paul E Croarkin; Astrid A Hoberg; Simon Kung; Renato D Alarcon; Nicola Keeth; Balwinder Singh; William V Bobo; Mark A Frye
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

7.  Psychiatric Genetics, Epigenetics, and Cellular Models in Coming Years.

Authors:  Chunyu Liu; Stephen V Faraone; Stephen J Glatt
Journal:  J Psychiatr Brain Sci       Date:  2019-08-22

8.  Integrating Patients' Expectations into the Management of Their Depression: Report of a Symposium at the European College of Neuropsychopharmacology Congress.

Authors:  Koen Demyttenaere; Ellen Frank; David Castle; Elif Cindik-Herbrüggen
Journal:  Adv Ther       Date:  2019-08-09       Impact factor: 3.845

9.  Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data.

Authors:  Dekel Taliaz; Amit Spinrad; Ran Barzilay; Zohar Barnett-Itzhaki; Dana Averbuch; Omri Teltsh; Roy Schurr; Sne Darki-Morag; Bernard Lerer
Journal:  Transl Psychiatry       Date:  2021-07-08       Impact factor: 6.222

10.  A Randomized Controlled Trial of Combinatorial Pharmacogenetics Testing in Adolescent Depression.

Authors:  Jennifer L Vande Voort; Scott S Orth; Julia Shekunov; Magdalena Romanowicz; Jennifer R Geske; Jessica A Ward; Nicole I Leibman; Mark A Frye; Paul E Croarkin
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2021-06-05       Impact factor: 13.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.